Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-06-16FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for metformin hydrochloride from Oceanside Pharmaceuticals.
-
FDA approval · 2009-06-15FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2009-06-15FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 insulin, manufactured by Novo Nordisk.
-
FDA approval · 2009-06-03FDA Approved: GLYBURIDE-METFORMIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves the original application for a generic glyburide/metformin hydrochloride combination tablet.
-
FDA approval · 2009-05-12FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for METFORMIN HYDROCHLORIDE from Aurobindo Pharma Limited, granting supplemental approval for this g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-05-07FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Novo Nordisk's NovoLog (insulin aspart).
-
FDA approval · 2009-05-07FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2009-05-06FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for glyburide, a generic antidiabetic medication used to treat ty…
-
FDA approval · 2009-05-05FDA Approved: CYCLOSET — Original Application (Avvisto Therapeutics LLC)
FDA approved CYCLOSET (bromocriptine mesylate) via an original NDA from Avvisto Therapeutics LLC, for the treatment of adults with type 2 di…
-
FDA approval · 2009-03-25FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental ANDA for Apotex Corp. to market GLIPIZIDE as a generic tablet for type 2 diabetes mellitus.
-
FDA approval · 2009-03-23FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic Glyburide and Metformin Hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2009-03-16FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The approval updates the product's labeling and/o…
-
FDA approval · 2009-03-16FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. The action updates the pro…
-
FDA approval · 2009-03-11FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Glipizide by ANI Pharmaceuticals, approving a generic version of the diabetes medication. It is …
-
FDA approval · 2009-03-05FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approved a supplemental application for glyburide submitted by TEVA Pharmaceuticals USA Inc.
-
FDA approval · 2009-02-24FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi U.S. LLC, resulting in an updated label for the product.
-
FDA approval · 2009-01-15FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Teva's generic combination tablet of glipizide and metformin hydrochloride.
-
FDA approval · 2009-01-04FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Actoplus Met (pioglitazone and metformin hydrochloride) submitted by Takeda, resulting in change…
-
FDA approval · 2009-01-04FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a Pioglitazone and Glimepiride fixed-dose combination. This approval co…
-
FDA approval · 2008-12-11FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc., approving changes to the…
-
FDA approval · 2008-11-28FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2008-11-28FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2008-11-28FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for Insulin aspart protamine and insulin aspart mix 70/30 (Novo Nordisk) to continue marketing this …
-
FDA approval · 2008-11-24FDA Approved: ACARBOSE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for acarbose submitted by Hikma Pharmaceuticals USA Inc., under ANDA078470. This represents regu…
-
FDA approval · 2008-11-21FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic glyburide and metformin hydrochloride combination from Aurobindo Pharma Limited.